DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE:COV), a leading global provider of healthcare products, today announced the appointment of Mark Trudeau as president of its Pharmaceuticals segment and a senior vice president of the Company, effective February 1.
Covidien is one of the world’s largest producers of bulk acetaminophen, the largest U.S. supplier of opioid pain medications and among the top 10 generic drug manufacturers in the U.S. The Company secured U.S. Food and Drug Administration approval of eight new pharmaceutical products since 2008, among which were two branded pain products launched in 2010.
Covidien is one of the world’s largest producers of bulk acetaminophen, the largest U.S. supplier of opioid pain medications and among the top 10 generic drug manufacturers in the U.S. The Company secured U.S. Food and Drug Administration approval of eight new pharmaceutical products since 2008, among which were two branded pain products launched in 2010.
